Cleared Traditional

K153044 - Sentimag System, Sentimark Magnetic Marker Systerm (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K153044 · Endomagnetics Ltd., · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2016
Decision
135d
Days
Class 2
Risk

K153044 is an FDA 510(k) clearance for the Sentimag System, Sentimark Magnetic Marker Systerm. Classified as Temporary Tissue Marker (product code PBY), Class II - Special Controls.

Submitted by Endomagnetics Ltd., (Cambridge, GB). The FDA issued a Cleared decision on March 2, 2016 after a review of 135 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4300 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Endomagnetics Ltd., devices

Submission Details

510(k) Number K153044 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 2015
Decision Date March 02, 2016
Days to Decision 135 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
21d slower than avg
Panel avg: 114d · This submission: 135d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PBY Temporary Tissue Marker
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4300
Definition To Temporarily (< 30 Days) Mark A Tissue Site Intended For Surgical Removal. The Tissue Marker Is Surgically Removed With The Target Tissue.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - PBY Temporary Tissue Marker

Devices cleared under the same product code (PBY) and FDA review panel - the closest regulatory comparables to K153044.
Sirius Pintuition Seed, Sirius Pintuition Probe, Sirius Pintuition Base Unit
K223682 · Sirius Medical Systems B.V. · Nov 2023
Sirius Pintuition Seed, Sirius Pintuition Probe, Sirius Pintuition Base Unit
K222643 · Sirius Medical Systems B.V. · Oct 2022
Sirius Pintuition Seed, Sirius Pintuition Probe, Sirius Pintuition Base Unit
K200734 · Sirius Medical Systems B.V. · Feb 2021